Cited by 109Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.

Type 2 diabetes mellitus, dyslipidemia, and Alzheimer’s disease

Open access

Carlsson, Cynthia M.·2010·Journal of Alzheimer s Disease

DOI 10.3233/jad-2010-100012PMC PMC4235787

Open this paper in CoChat — free account

Abstract

The prevalence of Alzheimer's disease (AD) is increasing rapidly, heightening the importance of finding effective preventive therapies for this devastating disease. Midlife vascular risk factors, including type 2 diabetes mellitus (T2DM), have been associated with increased risk of AD decades later and may serve as targets for AD prevention. Studies to date suggest that T2DM and hyperinsulinemia increase risk for AD, possibly through their effects on amyloid-beta metabolism and cerebrovascular dysfunction - two early findings in preclinical AD pathology. This paper reviews the evidence supporting a relationship between T2DM, hyperinsulinemia, and diabetic dyslipidemia on the development of AD, discusses DM treatment trials and their preliminary results on cognitive function, and proposes some strategies for optimizing future AD prevention trial design.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3233/jad-2010-100012

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“A few large clinical trials have shown that lifestyle interventions and antidiabetic medications, including metformin and rosiglitazone , prevent the development of T2DM in at-risk adults [101] [102] [103].”
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
(2006) · The Lancet · doi:10.1016/s0140-6736(06)69420-8 · Cited by 1,706
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,526
Viability thresholds and the penumbra of focal ischemia
Hossmann, K. (1994) · Annals of Neurology · doi:10.1002/ana.410360404 · Cited by 1,370
Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291

Show all 103 references

Sorted by citations

The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Lewczuk, P., Riederer, P. F., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramírez, A., Parnetti, L., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 318
Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease
Geekiyanage, H., Jicha, G. A., Nelson, P. T., & Chan, C. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.026 · Cited by 299
High fat diet induces brain insulin resistance and cognitive impairment in mice
Kothari, V. M., Luo, Y., Tornabene, T., O’Neill, A. M., Greene, M. W., Geetha, T., & Babu, J. R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.10.006 · Cited by 290
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Fernández-Calle, R., Konings, S. C., Frontiñán-Rubio, J., García-Revilla, J., Camprubí-Ferrer, L., Svensson, M., Martinson, I., Boza-Serrano, A., Venero, J. L., Nielsen, H. M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00566-4 · Cited by 278
Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
Tayeb, H. O., Yang, H. D., Price, B. H., & Tarazi, F. I. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.002 · Cited by 237
Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid‐life: A randomized trial
Hoscheidt, S. M., Sanderlin, A. H., Baker, L. D., Jung, Y., Lockhart, S. N., Kellar, D., Whitlow, C. T., Hanson, A. J., Friedman, S. D., Register, T. C., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12421 · Cited by 176
The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer’s Disease
Long-Smith, C. M., Manning, S., McClean, P. L., Coakley, M. F., O’Halloran, D., Hölscher, C., & O’Neill, C. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8199-5 · Cited by 158
Diabetes and Hypercholesterolemia Increase Blood-Brain Barrier Permeability and Brain Amyloid Deposition: Beneficial Effects of the LpPLA2 Inhibitor Darapladib
Acharya, N. K., Levin, E. C., Clifford, P. M., Han, M., Tourtellotte, R., Chamberlain, D., Pollaro, M., Coretti, N. J., Kosciuk, M. C., Nagele, E. P., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122254 · Cited by 121
Cardiovascular risk factors, cortisol, and amyloid‐β deposition in Alzheimer's Disease Neuroimaging Initiative
Toledo, J. B., Toledo, E., Weiner, M. W., Jack, C. R., Jagust, W., Lee, V. M. ‐., Shaw, L. M. J., & Trojanowski, J. Q. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.08.008 · Cited by 130
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?
Humpel, C. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.11.032 · Cited by 127
Blood–brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood–central nervous system interface
Phan, D. T. T., Bender, R. H. F., Andrejecsk, J. W., Sobrino, A., Hachey, S. J., George, S. C., & Hughes, C. C. W. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217694100 · Cited by 122
Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis’ still alive?
Tayeb, H. O., Murray, E. D., Price, B. H., & Tarazi, F. I. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.789856 · Cited by 119
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
Fišar, Z. (2022) · Biomolecules · doi:10.3390/biom12111676 · Cited by 113
Vascular and metabolic dysfunction in Alzheimer’s disease: a review
Murray, I. V. J., Proza, J. F., Sohrabji, F., & Lawler, J. M. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010355 · Cited by 104
Dietary Patterns and Alzheimer’s Disease: An Updated Review Linking Nutrition to Neuroscience
Ellouze, I., Sheffler, J., Nagpal, R., & Arjmandi, B. (2023) · Nutrients · doi:10.3390/nu15143204 · Cited by 104
Evaluating the Association between Diabetes, Cognitive Decline and Dementia
Ojo, O., & Brooke, J. M. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120708281 · Cited by 93
Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress
Baluchnejadmojarad, T., & Roghani, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.06.007 · Cited by 92
Amyloid-β and Tau Pathology of Alzheimer's Disease Induced by Diabetes in a Rabbit Animal Model
Bitel, C. L., Kasinathan, C., Kaswala, R. H., Klein, W. L., & Frederikse, P. H. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120571 · Cited by 78
Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?
Zhang, Y., & Song, W. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.001 · Cited by 79
Nutritional Biomarkers and Subsequent Cognitive Decline Among Community-Dwelling Older Japanese: A Prospective Study
Taniguchi, Y., Shinkai, S., Nishi, M., Murayama, H., Nofuji, Y., Yoshida, H., & Fujiwara, Y. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt286 · Cited by 71
Biomarkers of Alzheimer's disease and mild cognitive impairment: A current perspective
Lewczuk, P., Mroczko, B., Fagan, A. M., & Kornhuber, J. (2014) · Advances in Medical Sciences · doi:10.1016/j.advms.2014.11.002 · Cited by 73
The role of inflammatory processes in Alzheimer’s disease
Broussard, G. J., Mytar, J. O., Li, R., & Klapstein, G. J. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0130-z · Cited by 71
Parkinson';s Disease, Diabetes and Cognitive Impairment
Ashraghi, M. R., Pagano, G., Polychronis, S., Niccolini, F., & Politis, M. (2016) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214810999160628105549 · Cited by 68
Mitochondria and NMDA Receptor-Dependent Toxicity of Berberine Sensitizes Neurons to Glutamate and Rotenone Injury
Kysenius, K., Brunello, C. A., & Huttunen, H. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107129 · Cited by 65
Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer’s Disease
Goldwaser, E. L., Acharya, N. K., Sarkar, A., Godsey, G. A., & Nagele, R. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160284 · Cited by 64
Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation
Kim, B., Figueroa‐Romero, C., Pacut, C. M., Backus, C., & Feldman, E. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.636852 · Cited by 61
Effects of pioglitazone on the incidence of dementia in patients with diabetes
Chou, P., Ho, B., & Yang, Y. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.006 · Cited by 59
Identifying progressive imaging genetic patterns via multi-task sparse canonical correlation analysis: a longitudinal study of the ADNI cohort
Du, L., Liu, K., Zhu, L., Yao, X., Risacher, S. L., Guo, L., Saykin, A. J., Shen, L., & Initiative, A. D. N. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz320 · Cited by 59
High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status
Takalo, M., Haapasalo, A., Martiskainen, H., Kurkinen, K. M. A., Koivisto, H., Miettinen, P., Khandelwal, V. K. M., Kemppainen, S., Kamińska, D., Mäkinen, P. M., et al. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.02.003 · Cited by 55
Cerebral Myogenic Reactivity and Blood Flow in Type 2 Diabetic Rats: Role of Peroxynitrite in Hypoxia-Mediated Loss of Myogenic Tone
Kelly-Cobbs, A. I., Prakash, R., Coucha, M. M., Knight, R. A., Li, W., Ogbi, S. N., Johnson, M., & Ergul, A. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.191296 · Cited by 54
Retinal pathology is associated with increased blood–retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA 2 inhibitor Darapladib
Acharya, N. K., Qi, X., Goldwaser, E. L., Godsey, G. A., Wu, H., Kosciuk, M. C., Freeman, T. A., Macphee, C. H., Wilensky, R. L., Venkataraman, V., et al. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116683149 · Cited by 51
New Insight into Diabetes Management: From Glycemic Index to Dietary Insulin Index
Yari, Z., Behrouz, V., Zand, H., & Pourvali, K. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190614122626 · Cited by 52
A systematic review of type 2 diabetes mellitus and hypertension in imaging studies of cognitive aging: time to establish new norms
Meusel, L.-A., Kansal, N., Tchistiakova, E., Yuen, W., MacIntosh, B. J., Greenwood, C. E., & Anderson, N. D. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00148 · Cited by 49
Chronic Cyanidin‐3‐glucoside Administration Improves Short‐term Spatial Recognition Memory but not Passive Avoidance Learning and Memory in Streptozotocin‐diabetic Rats
Nasri, S., Roghani, M., Baluchnejadmojarad, T., Balvardi, M., & Rabani, T. (2012) · Phytotherapy Research · doi:10.1002/ptr.3702 · Cited by 47
Impact of Insulin Sensitizers on the Incidence of Dementia: A Meta-Analysis
Ye, F., Luo, Y.-J., Xiao, J. F., Yu, N., & Yi, G. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000445941 · Cited by 47
MST1 Regulates Neuronal Cell Death via JNK/Casp3 Signaling Pathway in HFD Mouse Brain and HT22 Cells
Khan, M., Rutten, B. P. F., & Kim, M. O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102504 · Cited by 45
Deep phenotyping of Alzheimer’s disease leveraging electronic medical records identifies sex-specific clinical associations
Tang, A. S., Oskotsky, T., Havaldar, S., Mantyh, W. G., Bicak, M., Solsberg, C. W., Woldemariam, S., Zeng, B., Hu, Z., Oskotsky, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28273-0 · Cited by 45
Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease
Ong, M., Foo, H., Chander, R. J., Wen, M., Au, W. L., Sitoh, Y. Y., Tan, L., & Kandiah, N. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.04.010 · Cited by 45
Autophagy Activation is Associated with Neuroprotection in Diabetes-associated Cognitive Decline
Wu, Y., Ye, L., Yuan, Y., Jiang, T., Guo, X., Wang, Z., Xu, K., Xu, Z., Liu, Y., Zhong, X., et al. (2018) · Aging and Disease · doi:10.14336/ad.2018.1024 · Cited by 41
Receptor-mediated toxicity of human amylin fragment aggregated by short- and long-term incubations with copper ions
Caruso, G., Distefano, D. A., Parlascino, P., Fresta, C. G., Lazzarino, G., Lunte, S. M., & Nicoletti, V. G. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2864-1 · Cited by 39
Navigating the intersection: Diabetes and Alzheimer's intertwined relationship
Kale, M. B., Bhondge, H. M., Wankhede, N. L., Shende, P. V., Thanekar, R., Aglawe, M. M., Rahangdale, S. R., Taksande, B. G., Pandit, S. B., Upaganlawar, A. B., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102415 · Cited by 38
Effects of Plasma Lipids and Statins on Cognitive Function
Li, R., Wang, T., Lyu, P., Liu, Y., Chen, W., Fan, M., & Xu, J. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.225062 · Cited by 40
Neuromodulatory effects of green coffee bean extract against brain damage in male albino rats with experimentally induced diabetes
Albrakati, A., Albarakati, A. J. A., Daabo, H. M. A., Baty, R. S., Salem, F. E. H., Habotta, O. A., Elmahallawy, E. K., Abdel-Mohsen, D. M., Taha, H., Akabawy, A. M. A., et al. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00583-6 · Cited by 37
Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer’s and Parkinson’s Diseases: Insights into Current Medications
Gautam, D., Naik, U. P., Naik, M. U., Yadav, S. K., Chaurasia, R. N., & Dash, D. (2023) · Biomolecules · doi:10.3390/biom13111609 · Cited by 38
The role of thyroid-stimulating hormone in regulating lipid metabolism: Implications for body–brain communication
Wang, X., Zhen, W., Liu, Y., Wu, C., Jiang, J., Hashimoto, K., & Zhou, X. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106658 · Cited by 41
Enhancement of Insulin/PI3K/Akt Signaling Pathway and Modulation of Gut Microbiome by Probiotics Fermentation Technology, a Kefir Grain Product, in Sporadic Alzheimer’s Disease Model in Mice
Sayed, N. S. E., Kandil, E. A., & Ghoneum, M. H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.666502 · Cited by 38
Short-term mechanisms influencing volumetric brain dynamics
Dieleman, N., Koek, H. L., & Hendrikse, J. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.09.002 · Cited by 32
Diabetes mellitus type 2 as an underlying, comorbid or consequent state of mental disorders
Borovčanin, M., Vesić, K., Petrović, I., Jovanović, I., & Mijailović, N. R. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.481 · Cited by 34
Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?
Kokjohn, T. A., Maarouf, C. L., & Roher, A. E. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.2429 · Cited by 31
Summative Effects of Vascular Risk Factors on the Progression of Alzheimer Disease
Lee, W., Liao, Y., Wang, Y.-F., Lin, Y., Wang, S., & Fuh, J. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16181 · Cited by 27
Hypothyroidism and Diabetes-Related Dementia: Focused on Neuronal Dysfunction, Insulin Resistance, and Dyslipidemia
Kim, H. K., & Song, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23062982 · Cited by 33
Curcugreen Treatment Prevented Splenomegaly and Other Peripheral Organ Abnormalities in 3xTg and 5xFAD Mouse Models of Alzheimer’s Disease
Manna, J., Dunbar, G. L., & Maiti, P. (2021) · Antioxidants · doi:10.3390/antiox10060899 · Cited by 26
Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study
Takagi, M., Ishigaki, Y., Uno, K., Sawada, S., Imai, J., Kaneko, K., Hasegawa, Y., Yamada, T., Tokita, A., Iseki, K., et al. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-76 · Cited by 25
Linking senile dementia to type 2 diabetes: role of oxidative stress markers, C-reactive protein and tumor necrosis factor-α
Ragy, M. M., & Kamal, N. N. (2017) · Neurological Research · doi:10.1080/01616412.2017.1312773 · Cited by 24
The Aqueous Extract of Portulaca Oleracea Ameliorates Neurobehavioral Dysfunction and Hyperglycemia Related to Streptozotocin-Diabetes Induced in Ovariectomized Rats.
Tabatabaei, S. R. F., Rashno, M., Ghaderi, S., & Askaripour, M. (2016) · PubMed Central · Cited by 24
Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal
Tsirulnikov, K., Abuladze, N. K., Bragin, A., Faull, K. F., Cascio, D., Damoiseaux, R. D., Schibler, M. J., & Pushkin, A. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.07.002 · Cited by 22
Cognitive deficits and Alzheimer-like neuropathological impairments during adolescence in a rat model of type 2 diabetes mellitus
Li, W., Jin, L., Li, Y.-P., Feng, Q., Ren, L., Wang, F., & Bo, G.-J. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.239448 · Cited by 22
Pioglitazone improves the ability of learning and memory via activating ERK1/2 signaling pathway in the hippocampus of T2DM rats
Gao, F., Zang, L., Wu, D. Y., Li, Y. J., Zhang, Q., Wang, H. B., Tian, G. L., & Mu, Y. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.04.052 · Cited by 20
You-on-a-chip’ for precision medicine
Low, L. A., & Tagle, D. A. (2018) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2018.1456333 · Cited by 18
Insights into prevention mechanisms of bioactive components from healthy diets against Alzheimer's disease
Wang, J., Yu, Z., Ye, P., & Xu, B. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109397 · Cited by 18
Novel Biomarkers for Alzheimer’s Disease: Plasma Neurofilament Light and Cerebrospinal Fluid
Abukuri, D. N. (2024) · International Journal of Alzheimer s Disease · doi:10.1155/2024/6668159 · Cited by 23
The influence of insulin infusion on the metabolism of amyloid β peptides in plasma
Karczewska‐Kupczewska, M., Lelental, N., Adamska, A., Nikołajuk, A., Kowalska, I., Górska, M., Zimmermann, R., Kornhuber, J., Strączkowski, M., & Lewczuk, P. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.01.013 · Cited by 18
Alzheimer's disease and type 2 diabetes: Two diseases, one common link?
Bartl, J., Monoranu, C., Schilling, A.-K., Kolter, J. F., Riederer, P., & Grünblatt, E. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.650204 · Cited by 17
Current Insights of Nanocarrier-Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer’s Disease
Jain, U., Johari, S., & Srivastava, P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03671-7 · Cited by 16
Protein Modification by Dicarbonyl Molecular Species in Neurodegenerative Diseases
Williams, W. M., Weinberg, A., & Smith, M. A. (2011) · Journal of Amino Acids · doi:10.4061/2011/461216 · Cited by 16
Comparative study of cholinergic and oxidative stress biomarkers in brains of diabetic and hypercholesterolemic rats
Hegazy, A., Abdel-Azeem, A. S., Shahy, E. M., & El-Sayed, E. M. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327115583361 · Cited by 16
Coenzyme Q10 supplementation reverses diabetes-related impairments in long-term potentiation induction in hippocampal dentate gyrus granular cells: An in vivo study
Omidi, G., Karimi, S. A., Shahidi, ‬., Faraji, N., & Komaki‬, A. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146475 · Cited by 15
Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights
Sanaie, S., Nikanfar, S., Yousefi, Z., Azizi-Zeinalhajlou, A., Sadigh‐Eteghad, S., Araj‐Khodaei, M., Ayati, M. H., & Andalib, S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01059-5 · Cited by 15
Improving effect of Actinidia arguta leaf on hyperglycemia-induced cognitive dysfunction
Yoo, S. K., Kang, J. Y., Lee, U., Park, S. K., Kim, J. M., Han, H. J., Kim, D., & Heo, H. J. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104315 · Cited by 13
The Interaction Between Vascular Risk Factors, Cerebral Small Vessel Disease, and Amyloid Burden in Older Adults
Koncz, R., Initiative, A. D. N., Wen, W., Makkar, S. R., Lam, B. C. P., Crawford, J. D., Rowe, C. C., & Sachdev, P. S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-210358 · Cited by 12
Neuroimaging correlates of Alzheimer's disease biomarker concentrations in a racially diverse high‐risk cohort of middle‐aged adults
Misiura, M. B., Munkombwe, C., Igwe, K. C., Verble, D. D., Likos, K. D. S., Minto, L. R., Bartlett, A., Zetterberg, H., Turner, J. A., Dotson, V. M., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14051 · Cited by 9
Mechanistic Approach to Immunity and Immunotherapy of Alzheimer’s Disease: A Review
Islam, M. R., Rabbi, M. A., Hossain, T., Sultana, S., & Uddin, S. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00360 · Cited by 10
Genetic polymorphisms of lipid metabolism gene SAR1 homolog B and the risk of Alzheimer's disease and vascular dementia
Chen, J., Hsieh, C.-J., Huang, Y., Chen, Y., Chen, T., Sun, Y., Wen, L., Yip, P., & Chu, Y. (2015) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2015.01.008 · Cited by 10
Clinical characteristics of cognitive impairment and its related risk factors in post‐stroke epilepsy
Hou, H., Sun, G., Duan, Z., Tao, L., Zhang, S., & Fang, Q. (2022) · Epileptic Disorders · doi:10.1684/epd.2022.1442 · Cited by 9
Risk of Dementia in Diabetic Patients with Hyperglycemic Crisis: A Nationwide Taiwanese Population-Based Cohort Study
Chou, C., Feng, I., Chen, Y., Chen, J., Lin, H., Wang, J., Hsu, C., & Huang, C. (2020) · Neuroepidemiology · doi:10.1159/000509754 · Cited by 9
Cerebrovascular and Blood-Brain Barrier Compromise: A Mechanistic Link between Vascular Disease and Alzheimer’s Disease Subtypes of Neurocognitive Disorders
Goldwaser, E. L., Acharya, N. K., & Nagele, R. G. (2015) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000013 · Cited by 8
Optimizing clinical phenotyping to better delineate the complex relationship between type 2 diabetes and Alzheimer’s disease
Hanson, A. J., & Rubinow, K. B. (2021) · Clinical and Translational Science · doi:10.1111/cts.13024 · Cited by 8
Lipidomics and cognitive dysfunction – A Narrative review
Chakraborty, A., Praharaj, S. K., Prabhu, R. V. K., & Prabhu, M. M. (2020) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2020-0134 · Cited by 8
The relationship between urinary Alzheimer-associated neuronal thread protein and blood biochemical indicators in the general population
Li, Y., Guan, S., He, J., Liu, H., Kang, M., Wang, X., Sheng, C., Sun, Y., Li, X., Fang, X., et al. (2020) · Aging · doi:10.18632/aging.103356 · Cited by 8
Alzheimer’s Disease: Current and Future Treatments. A Review
Chou, E. (2014) · International Journal of Medical Students · doi:10.5195/ijms.2014.85 · Cited by 8
Effects of Artemisia macrocephala Jacquem on Memory Deficits and Brain Oxidative Stress in Streptozotocin-Induced Diabetic Mice
Bari, A. U., Shah, S. M. M., Al-Joufi, F. A., Shah, S. W. A., Shoaib, M., Shah, I., Zahoor, M., Ahmed, M. N., Ghias, M., Shah, S. M. H., et al. (2022) · Molecules · doi:10.3390/molecules27082399 · Cited by 7
THE EFFECT OF SEMBUNG LEAF EXTRACT (BLUMEA BALSAMIFERA) ON THE NUMBER AND DIAMETER OF RATS LEYDIG CELLS INDUCED BY HIGH-FAT DIET
Widhiantara, G., Permatasari, A. A. A. P., & Wiradana, P. A. (2021) · PLANT ARCHIVES · doi:10.51470/plantarchives.2021.v21.no1.049 · Cited by 6
Lipoprotein binding to anionic biopolyelectrolytes and the effect of glucose on nanoplaque formation in arteriosclerosis and Alzheimer's disease
Siegel, G., Mockenhaupt, F. P., Behnke, A., Ermilov, E. A., Winkler, K. E., Pries, A. R., Malmsten, M., Hetzer, R., Saunders, R., & Lindman, B. (2016) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2016.02.001 · Cited by 6
Methylation factor MRPL15 identified as a potential biological target in Alzheimer’s disease
Gao, L., Li, J., Yan, M., & Aili, M. (2021) · Aging · doi:10.18632/aging.202862 · Cited by 7
EFFECT OF METFORMIN AND SIMVASTATIN IN DIAZEPAM-AND SODIUM NITRITE-INDUCED ANTEROGRADE AMNESIA IN MALE SWISS ALBINO MICE
Ss, T., & Sugato, C. H. (2018) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2018v10i6.19113 · Cited by 5
Vascular Risk Factors and Cognition in Multiple System Atrophy
Zhang, L., Hou, Y., Cao, B., Wei, Q., Ou, R., Liu, K., Lin, J., Yang, T., Xiao, Y., Zhao, B., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.749949 · Cited by 5
Metabolic Syndrome and Dementia
Lee, A. Y. (2011) · Journal of the Korean Neurological Association · Cited by 6
Memory-Enhancing Effects of Daidzin, Possibly Through Dopaminergic and AChEergic Dependent Pathways
Islam, M. T., Prottay, A. A. S., Bhuia, M. S., Akbor, M. S., Chowdhury, R., Ansari, S. A., Ansari, I. A., Islam, M. A., Tahim, C. M., & Coutinho, H. D. M. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.04.024 · Cited by 4
The Effect of Cognitive Training in a Day Care Center in Patients with Early Alzheimer’s Disease Dementia: A Retrospective Study
Kwon, H. S., Yang, H.-R., Yun, K., Baek, J. S., Kim, Y. U., Park, S.-H., & Choi, H. (2020) · Psychiatry Investigation · doi:10.30773/pi.2020.0170 · Cited by 5
Stearoyl-CoA desaturases sustain cholinergic excitation and copulatory robustness in metabolically aging C. elegansmales
Goncalves, J. F., Yu, W. C., & Garcia, L. R. (2021) · iScience · doi:10.1016/j.isci.2022.104082 · Cited by 4
Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment
Lewczuk, P. (2014) · Advances in Geriatrics · doi:10.1155/2014/891780 · Cited by 3
Cognitive screening in patients with diabetes in primary care
Brooke, J. M., & Ojo, O. (2014) · British Journal of Community Nursing · doi:10.12968/bjcn.2014.19.8.401 · Cited by 3
16. The relationship between cholesterol metabolism and inflammation in chronic disease
Andersen, C. J., Doerr, A., Murphy, K. E., & McNeely, T. L. (2016) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-821-6_16 · Cited by 3
APOE gene region methylation is associated with cognitive performance in middle-aged urban adults
Shen, B., Hernandez, D. G., Chitrala, K. N., Kuczmarski, M. F., Hooten, N. N., Pacheco, N. L., Mode, N. A., Zonderman, A. B., Ezike, N., & Evans, M. K. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.010 · Cited by 3
China should emphasize understanding and standardized management in diabetic cognitive dysfunction
Yin, Q., Yan, G., Wang, X., Li, S., Hou, X., & Bi, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1195962 · Cited by 3
Role of Hypertension and Hyperlipidemia in the Pathogenesis of Dementia
Kaira, M., Walia, V., & Garg, M. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_10 · Cited by 3
β -1,3-Glucans-rich Euglena gracilis supplementation alleviates high-fat-high-fructose diet-induced cognitive impairment in middle-aged mice via the gut-brain axis
Xu, H., Wang, Y., Li, X., Wu, X., Lu, L. W., He, J., Wang, M., Liu, B., Xu, H., Chen, J., et al. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250284 · Cited by 2
From Herbal Tea to Science: Phytochemical and Biological Investigation of Ajuga chamaepitys subsp. chia (Lamiaceae) With Molecular Docking Analysis
Aydın, B., Aydın, A. S., Çeçen, Ö., Yuca, H., Bona, G. E., Demırcı, B., Bona, M., & Karakaya, S. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70749 · Cited by 2
Genomic Linkage Between Alzheimer's Disease and Type 2 Diabetes
Nedjadi, T., Haque, A., Alam, Q., Gan, S. H., Chaudhary, A., Abuzenadah, A. M., Damanhouri, G. A., & Kamal, M. A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660140 · Cited by 2

Authors: Carlsson, C. M.
Affiliations: University of Wisconsin–Madison (US)
Corresponding author: Carlsson, Cynthia M.
ORCID: Carlsson, Cynthia M.
Venue: Journal of Alzheimer s Disease
Publisher: SAGE Publications
Published: 2010-05-26
Volume: 20
Issue: 3
Pages: 711-722
ISSN: 1387-2877 (ISSN-L)
1875-8908
DOI: 10.3233/jad-2010-100012
PMC: PMC4235787
OpenAlex: W1570302318
Cited by: 109
References: 103
Citations by year: 2025: 3 · 2024: 6 · 2023: 7 · 2022: 13 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 9 · 2016: 9 · 2015: 6 · 2014: 9 · 2013: 3 · 2012: 11
FWCI: 5.23
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Alzheimer s Disease (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Geriatric Research Education and Clinical Center
National Institute on Aging (K23AG026752, P50AG033514)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: type 2 diabetes, Alzheimer's disease
MeSH terms: Alzheimer Disease, Animals, Diabetes Mellitus, Type 2, Humans, Risk Factors, Diabetes Complications, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Type 2 diabetes mellitus, dyslipidemia, and Alzheimer’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks